We found that the inhibition of EZH2 efficiently restored nuclear ERα expression in LMx-Al-cultured MMECs, TNBC cell line aggregates, and both PDEC-N and PDEC-BC explants (Fig. 6b, c). Here, EZH2 is linked to breast cancer.